| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |